The primary purpose of this funding opportunity announcement (FOA) is to support and facilitate multidisciplinary approaches towards the development of new and/or improved contraceptive methods for both men and women through the formation of a Contraceptive Research Development Center. This FOA also allows the inclusion of translational studies to facilitate the pre-clinical to clinical transition and increase the likelihood of clinical success. Additionally, it allows for behavioral and social science research projects to study contraceptive use and non-use of marketed products or products in clinical development. The Center will serve as a national resource for development of early stage investigators electing to pursue careers in contraceptive research.
Deadlines:
RFA-HD-21-011 Expiration Date January 7, 2021
A Center should propose a budget that reflects the actual needs of the proposed projects and costs; the budget must not exceed $1.3 million per year in direct costs, excluding third party F&A.
The scope of the proposed project should determine the project period. The maximum project period is 5 years.
